News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Biohacker Aaron Traywick Found Dead in DC Float Spa
Ashley Yeager | May 1, 2018
The CEO of a biomedical startup had made headlines this year when he injected himself with an untested herpes vaccine in front of an audience.
New Ovarian Cancer Vaccine Shows Promise
Catherine Offord | Apr 12, 2018
A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
Opinion: We Have Been Naive About Naive T Cells
José A.M. Borghans, Femke van Wijk, Theo van den Broek | Apr 6, 2018
Human naive T cells are far more heterogeneous than has long been appreciated, having implications for vaccine strategies.
Ruth Nussenzweig, Malaria Researcher, Dies
Jim Daley | Apr 5, 2018
The microbiologist’s research led to the development of the first human malaria vaccine.
Waning Protection from Vaccination Explains Rise in Mumps Cases
Catherine Offord | Mar 22, 2018
A study finds that the vaccine’s effects wear off as a person ages, suggesting a need for booster shots.
AIDS Researcher Emerges as Top Candidate to Head CDC
Ashley Yeager | Mar 19, 2018
Robert Redfield would replace Brenda Fitzgerald, who resigned in January over unresolved conflicts of interest.
Recipients of Experimental Herpes Vaccine File Lawsuit
Catherine Offord | Mar 15, 2018
The suit claims that Rational Vaccines, the company of recently deceased researcher William Halford, violated US and international laws when it carried out the procedure.
Flu and Whooping Cough Vaccines Don’t Harm Babies: Study
Kerry Grens | Feb 21, 2018
Infants whose moms received the shots when they were pregnant were no more at risk of dying or being hospitalized than other babies.
European Measles Cases Quadrupled in 2017
Shawna Williams | Feb 20, 2018
The increase is attributed to a drop in immunization rates.
CDC: Flu Vaccine 36 Percent Effective So Far
Catherine Offord | Feb 16, 2018
The vaccine shows better-than-expected effectiveness against the most common and most virulent strain of influenza in children under 9 years old.